Your browser doesn't support javascript.
loading
Increasing intracellular bioavailable copper selectively targets prostate cancer cells.
Cater, Michael A; Pearson, Helen B; Wolyniec, Kamil; Klaver, Paul; Bilandzic, Maree; Paterson, Brett M; Bush, Ashley I; Humbert, Patrick O; La Fontaine, Sharon; Donnelly, Paul S; Haupt, Ygal.
Affiliation
  • Cater MA; Research Division, Peter MacCallum Cancer Centre, East Melbourne, Victoria 3002, Australia.
ACS Chem Biol ; 8(7): 1621-31, 2013 Jul 19.
Article in En | MEDLINE | ID: mdl-23656859
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organometallic Compounds / Prostatic Neoplasms / Drug Delivery Systems / Copper Limits: Animals / Humans / Male Language: En Journal: ACS Chem Biol Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Organometallic Compounds / Prostatic Neoplasms / Drug Delivery Systems / Copper Limits: Animals / Humans / Male Language: En Journal: ACS Chem Biol Year: 2013 Document type: Article Affiliation country: Country of publication: